#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Idiopathic pulmonary fibrosis Langerhans cell sarcoma Neovascular age-related macular degeneration Neuroblastoma Acquired haemophilia Myeloid leukaemia Chronic myelomonocytic leukaemia Hereditary motor and sensory neuropathy Transitional cell carcinoma Extra-osseous Ewing's sarcoma Giant cell tumour of tendon sheath Pyruvate dehydrogenase complex deficiency Hypotransferrinaemia Prodromal Alzheimer's disease Hypertriglyceridaemia More trials…
Learn about Rare Diseases

Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Glycogen storage disease type I – Basic Information Activated PI3 kinase delta syndrome – Basic Information Ewing’s sarcoma recurrent – Life with Disease Friedreich’s ataxia – Trials in Disease Systemic sclerosis pulmonary – Treatment VEXAS syndrome – Treatment Sarcoidosis Gastrointestinal stromal tumour – Life with Disease Mast cell activation syndrome – Treatment More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Pseudoephedrine Hydrochloride Botulinum Toxin Type A Ephedrine Hydrochloride Iomeprol Alanine Soya-Bean Oil Refined Interferon Beta-1B ALKYLATING AGENTS Riboflavin Sodium Phosphate Specific Nucleic Acid Sna-Ebv Amlodipine Lorazepam Etravirine Rbl027.2 Ontasameran Alternaria Alternata Extract Mezigdomide Venlafaxine Hydrochloride PICLIDENOSON Redasemtide More therapies…

Learn about Your Condition

Partial lipodystrophy Malignant lymphoid neoplasm Transplant rejection Metastatic malignant melanoma Electrocorticogram Cardiac sarcoidosis Cerebral palsy Benign renal neoplasm Hyperphagia Liposarcoma Malignant melanoma stage II Primary hypercholesterolaemia Vesicoureteric reflux Chorea Nephrolithiasis More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Myeloid leukaemia

Study on Ponatinib for Treating Recurrent or Refractory Leukemias and Solid Tumors in Children

Recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
- Ponatinib
Study Comparing Pevonedistat, Venetoclax, and Azacitidine with Venetoclax and Azacitidine in Adults with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy

Not recruiting

2 1 1 1
Investigated Drugs:

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Myeloid leukaemia

Study on Ponatinib for Treating Recurrent or Refractory Leukemias and Solid Tumors in Children

Study Comparing Pevonedistat, Venetoclax, and Azacitidine with Venetoclax and Azacitidine in Adults with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies